UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT 2.0)

The UCLA SCTC GIT 2.0 was developed to assess SSc-related GIT symptoms severity and impact of GIT symptoms on emotional and social functioning

Refinement of the previously developed scleroderma gastrointestinal tract (SSC-GIT 1.0) instrument.

Khanna D, Hays RD, Maranian P, Seibold JR, Impens A, Mayes MD, Clements PJ, Getzug T, Fathi N, Bechtel A, Furst DE. Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. Arthritis Rheum. 2009 Sep 15;61(9):1257-63. doi: 10.1002/art.24730. PMID: 19714600; PMCID: PMC2767193. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767193]

The items are scored on a 0 to 3 possible range, where 0 indicates better health and 3 indicates worse health except for questions 15 and 31, which are scored on 0 (better health) and 1 (worse health) possible range.  For full scoring guide please contact uclasctcgit@rws.com.

This section to be updated later

Click here for report. 

Please click here for more information.

This section to be updated later

The UCLA SCTC GIT 2.0 requires permission to use.  Both commercial and non-commercial users must complete a license agreement before the scale may be used.  

Commercial use in for-profit studies or projects is subject to a license fee.

Please contact uclasctcgit@rws.com to request permission to use the UCLA SCTC GIT 2.0.

Afrikaans (South Africa)

Arabic (Israel)

Bengali (India)

Chinese (S) (China)

Chinese (S) (Malaysia)

Chinese (S) (Singapore)

Chinese (T) (Taiwan)

Czech (Czech Rep.)

Danish (Denmark)

Dutch (Belgium)

Dutch (Netherlands)

English (Australia)

English (Canada)

English (India)

English (Ireland)

English (Malaysia)

English (New Zealand)

English (Singapore)

English (South Africa)

English (UK)

Estonian (Estonia)

Finnish (Finland)

French (Belgium)

French (Canada)

French (France)

French (Switzerland)

German (Austria)

German (Belgium)

German (Germany)

German (Switzerland)

Greek (Greece)

Gujarati (India)

Hebrew (Israel)

Hindi (India)

Hungarian (Hungary)

Italian (Italy)

Italian (Switzerland)

Japanese (Japan)

Kannada (India)

Korean (South Korea)

Lithuanian (Lithuania)

Malay (Malaysia)

Malay (Singapore)

Malayalam (India)

Marathi (India)

Norwegian (Norway)

Polish (Poland)

Portuguese (Brazil)

Portuguese (Portugal)

Punjabi (India)

Romanian (Romania)

Russian (Estonia)

Russian (Israel)

Russian (Lithuania)

Russian (Russia)

Russian (Ukraine)

Serbian (Latin) (Serbia)

Spanish (Argentina)

Spanish (Chile)

Spanish (Colombia)

Spanish (Mexico)

Spanish (Peru)

Spanish (Puerto Rico)

Spanish (Spain)

Spanish (US)

Swedish (Sweden)

Tamil (India)

Tamil (Malaysia)

Tamil (Singapore)

Telugu (India)

Thai (Thailand)

Turkish (Turkey)

Ukrainian (Ukraine)

Urdu (India)

Vietnamese (Vietnam)

Xhosa (South Africa)

The University of California Los Angeles Scleroderma Clinical Trials Consortium gastrointestinal tract 2.0 (UCLA GIT 2.0) questionnaire is a self-reported tool measuring gastrointestinal (GI) quality of life in systemic sclerosis (SSc) patients.

The 1-week recall period was included based on cognitive debriefing from patients with systemic sclerosis and GI involvement.

The UCLA SCTC GIT 2.0 may not be modified without the consent and knowledge of the copyright holder.

Although it has not been evaluated for face-to-face and telephone administration, it is possible to use these interviewer modes of data collection. Theinstrument is designed to be used in clinical trials and clinical care.

The UCLA SCTC GIT 2.0 may be reformatted (e.g., different font, boxes, or blanks) to make it consistent with other instruments used in a study.  Formatting modifications must be approved by the copyright holder/RWS Life Sciences.

The instrument may not be reproduced in whole or in part without the express written permission of the copyright holder. To obtain permission to use the instrument, please submit a request through this website. 

Additionally, we ask users to notify us when they publish or UCLA SCTC GIT 2.0 data so that this information can be added to our web site.

Please contact RWS Life Sciences, exclusive translation provider of the UCLA SCTC GIT 2.0, to obtain a quotation for development of any new languages.

License Fee (per License)	$10,000
Cost for each translated instrument	$500/ instrument
Wire Transfer Fee	$15
Administrative fee	US$350

No fee for non-commercial users

Please click here for more information.